MTOR and neoplasm with perivascular epithelioid cell differentiation: Although the use of mTOR inhibitors in the management of TSC-associated tumors is well established, and initial studies have demonstrated their potential efficacy in PEComas, surgical intervention currently constitutes the central component of therapy for uterine PEComas [129, 132, 133].